These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1604489

  • 21. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R, Chargui J, Aitouche A, Veyron P, Touraine JL.
    Transplantation; 2000 Apr 15; 69(7):1452-7. PubMed ID: 10798770
    [Abstract] [Full Text] [Related]

  • 22. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T, Hancock WW, Monaco AP, Maki T.
    Transplantation; 1998 Apr 27; 65(8):1036-43. PubMed ID: 9583862
    [Abstract] [Full Text] [Related]

  • 23. Prolonged Hya-disparate skin graft survival in ethanol-consuming mice: correlation with impaired delayed hypersensitivity.
    Wang K, Busker-Mannie AE, Hoeft J, Vasquez K, Miller SD, Melvold RW, Waltenbaugh C.
    Alcohol Clin Exp Res; 2001 Oct 27; 25(10):1542-8. PubMed ID: 11696676
    [Abstract] [Full Text] [Related]

  • 24. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M, Suto R, Obata Y, Udono H, Takahashi T, Shiku H, Nakayama E.
    J Exp Med; 1991 Jul 01; 174(1):193-201. PubMed ID: 1905338
    [Abstract] [Full Text] [Related]

  • 25. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S, Kitagawa S, Iwata H, Ochiai T, Isono K, Hamaoka T, Fujiwara H.
    J Exp Med; 1992 Jan 01; 175(1):99-109. PubMed ID: 1730930
    [Abstract] [Full Text] [Related]

  • 26. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL, Lipsky PE.
    J Immunol; 1986 Aug 15; 137(4):1399-406. PubMed ID: 3488348
    [Abstract] [Full Text] [Related]

  • 27. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA, Taylor PA, Sprent J, Blazar BR.
    Transplantation; 1994 Jan 15; 57(2):249-56. PubMed ID: 7906058
    [Abstract] [Full Text] [Related]

  • 28. Tumor necrosis factor is critical for cytolytic T cell activity against allospecific hepatocytes and splenic targets in major histocompatibility complex class I disparate graft versus host disease.
    Ali S, Starwalt R, Kreck J, Whittington B, Brown GR.
    J Interferon Cytokine Res; 2011 May 15; 31(5):423-31. PubMed ID: 21091241
    [Abstract] [Full Text] [Related]

  • 29. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H.
    J Immunol; 1989 Sep 01; 143(5):1447-52. PubMed ID: 2527264
    [Abstract] [Full Text] [Related]

  • 30. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.
    J Clin Invest; 1999 Aug 01; 104(3):317-25. PubMed ID: 10430613
    [Abstract] [Full Text] [Related]

  • 31. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
    Lowry RP, Forbes RD, Blackburn JH, Marghesco DM.
    Transplantation; 1985 Nov 01; 40(5):545-50. PubMed ID: 3904091
    [Abstract] [Full Text] [Related]

  • 32. Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes.
    Brown GR, McGuire MJ, Thiele DL.
    J Immunol; 1993 Jun 01; 150(11):4733-42. PubMed ID: 8496587
    [Abstract] [Full Text] [Related]

  • 33. Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow.
    Blazar BR, Taylor PA, Sehgal SN, Vallera DA.
    Blood; 1994 Jan 15; 83(2):600-9. PubMed ID: 8286755
    [Abstract] [Full Text] [Related]

  • 34. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST, Wren SM, Oh E, Hronakes ML.
    Transplantation; 1991 Jun 15; 51(6):1262-7. PubMed ID: 1828637
    [Abstract] [Full Text] [Related]

  • 35. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplantation; 1992 Apr 15; 53(4):849-57. PubMed ID: 1533070
    [Abstract] [Full Text] [Related]

  • 36. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
    Surquin M, Le Moine A, Flamand V, Rombaut K, Demoor FX, Salmon I, Goldman M, Abramowicz D.
    Transplantation; 2005 Nov 27; 80(10):1485-92. PubMed ID: 16340795
    [Abstract] [Full Text] [Related]

  • 37. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U, Choksi S, Marcucci L, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):421-9. PubMed ID: 9647252
    [Abstract] [Full Text] [Related]

  • 38. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K, Gondo H, Nomoto K.
    J Immunol; 1984 Oct 01; 133(4):1735-9. PubMed ID: 6088626
    [Abstract] [Full Text] [Related]

  • 39. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
    Khan A, Tomita Y, Sykes M.
    Transplantation; 1996 Aug 15; 62(3):380-7. PubMed ID: 8779687
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.